[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336805-105":59,"doc-detail-336805-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","high-ntrk2-protein-expression-levels-may-be-associated-with-poorer-prognosis-of-breast-cancer-patients","High NTRK2 protein expression levels may be associated with poorer prognosis of breast cancer patients","","The study investigates the ambiguous role of neurotrophic receptor tyrosine kinase 2 (NTRK2) in breast cancer and evaluates whether NTRK2 protein expression relates to disease prognosis and treatment response. A retrospective analysis assessed NTRK2 expression in 131 breast cancer tissues and 56 adjacent normal tissues using immunohistochemistry. Chemotherapy sensitivity was estimated with pRRophetic, while immunotherapy sensitivity was inferred from The Cancer Immunome Atlas. High NTRK2 expression predicted poorer outcomes and showed increased sensitivity to selected therapies.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/high-ntrk2-protein-expression-levels-may-be-associated-with-poorer-prognosis-of-breast-cancer-patients/336805/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/high-ntrk2-protein-expression-levels-may-be-associated-with-poorer-prognosis-of-breast-cancer-patients/336805.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why did the study focus on NTRK2 in breast cancer?","Question",{"text":112,"@type":113},"Prior research reported conflicting findings about the prognostic role of NTRK2 in breast cancer, leaving its biological function unclear. The study aimed to clarify the relationship using clinical expression data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was NTRK2 protein expression measured?",{"text":117,"@type":113},"NTRK2 protein expression patterns were assessed using immunohistochemistry on breast cancer tissue samples and adjacent normal tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What did high NTRK2 expression indicate about prognosis?",{"text":121,"@type":113},"High NTRK2 expression acted as an independent risk factor and was linked to a less favorable prognosis in breast cancer patients.",{"name":123,"@type":110,"acceptedAnswer":124},"How did NTRK2 expression relate to treatment sensitivity?",{"text":125,"@type":113},"The high NTRK2 group showed increased sensitivity to certain chemotherapy drugs and higher immune checkpoint blockade therapy scores compared with the low NTRK2 group.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336805,1790998830,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":41,"preview_page_count":19,"preview_urls":149},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","High NTRK2 protein expression levels may be associated with poorer prognosis of breast cancer patients  \nRui Zhang 1,* , Jianguo Zhao 1,* and Lu Zhao2   \nJournal of International Medical Research 2024, Vol. 52(9) 1–12! The Author(s) 2024 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605241281322](DOI: 10.1177/03000605241281322)[ ](DOI: 10.1177/03000605241281322)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nObjective: Previous research has shown that the role of neurotrophic receptor tyrosine kinase 2 (NTRK2) in breast cancer (BRCA) remains ambiguous. To help elucidate this, we conducted a retrospective study to investigate the relationship between NTRK2 protein expression and BRCA.  \nMethods: The prognostic significance of NTRK2 protein expression patterns was assessed by performing immunohistochemistry assays on 131 BRCA tissues and 56 adjacent normal tissues ina retrospective study. Furthermore, the sensitivity to chemotherapeutic drugs was quantified by“pRRophetic” and the sensitivity to immunotherapy was estimated using The Cancer Immunome Atlas website.  \nResults: NTRK2 protein was expressed at significantly higher levels in BRCA samples compared with normal tissues. The data indicated that NTRK2 expression is an independent risk factor for BRCA patient prognosis. Additionally, the high NTRK2 group exhibited increased sensitivity to certain chemotherapy drugs and achieved higher scores for immune checkpoint blockade therapy compared with the low NTRK2 group.  \nConclusions: Our study demonstrated that higher NTRK2 protein expression is related to a less favorable prognosis in BRCA patients, as well as to enhanced sensitivity to specific chemotherapy and immunotherapy drugs.  \n1 Department of Thyroid and Breast Surgery, Wuhan No. 1 Hospital, Wuhan, China  \n2Department of Thyroid and Breast Surgery, Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China  \n*These authors contributed equally to this work.  \nCorresponding author:  \nLu Zhao, Department of Thyroid and Breast Surgery, Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan 430030, China.  \nEmail: [luzhao268@outlook.com](luzhao268@outlook.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nKeywords  \nNeurotrophic receptor tyrosine kinase 2, breast cancer, prognosis, chemotherapy, immunotherapy, biomarker  \nDate received: 15 October 2023; accepted: 21 August 2024  \nIntroduction  \nEpidemiological data have suggested that breast cancer (BRCA) is the most commonly diagnosed female cancer.1 With the rise in life expectancy and rapid development of diagnostic techniques, the BRCA incidence rate has been increasing annually. Recent studies employing high-throughput sequencing-based comparisons of tumor tissues and normal tissues have identified several genes that are preferentially expressed or frequently mutated in BRCA. These include BRCA1, BRCA2, ERBB2, ERa, and JAK2, which act as oncogenes in BRCA.2 Multiphase tumorigenesis in BRCA involves the development, progression, and invasion of tumors.3 Consequently, it is imperative to elucidate the underlying mechanisms and identify innovative reliable biomarkers to support effective therapeutic development for BRCA.  \nThe neurotrophic receptor tyros","cbCaidlKesFQNHVB","https://ap.wps.com/l/cbCaidlKesFQNHVB","pdf",978054,12,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Materials and methods","[{\"question\":\"Why did the study focus on NTRK2 in breast cancer?\",\"answer\":\"Prior research reported conflicting findings about the prognostic role of NTRK2 in breast cancer, leaving its biological function unclear. The study aimed to clarify the relationship using clinical expression data.\"},{\"question\":\"How was NTRK2 protein expression measured?\",\"answer\":\"NTRK2 protein expression patterns were assessed using immunohistochemistry on breast cancer tissue samples and adjacent normal tissues.\"},{\"question\":\"What did high NTRK2 expression indicate about prognosis?\",\"answer\":\"High NTRK2 expression acted as an independent risk factor and was linked to a less favorable prognosis in breast cancer patients.\"},{\"question\":\"How did NTRK2 expression relate to treatment sensitivity?\",\"answer\":\"The high NTRK2 group showed increased sensitivity to certain chemotherapy drugs and higher immune checkpoint blockade therapy scores compared with the low NTRK2 group.\"}]","High NTRK2 protein expression levels may be associated with poorer prognosis of breast cancer patients | PDF",1790016683,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/748d1e582779a630b895fed1af09b40e.webp",983,1399,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50d393ed3c15b97a30701bd37d18ebdc.webp",982,1398,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60845e576c5436f5ff0b8c4405a14e87.webp",981,1396,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af57aa3024ed56d0a41908e3e7bc3a4e.webp",980,1395]